Log in

600161 Beijing Tiantan Biological Products Corporation Limited SSE · China

Beijing Tiantan Biological Products Corporation (600161) news

Beijing Tiantan Biological Products Corporation Limited is a public biotech or pharmaceutical company listed on SSE under the ticker 600161, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Beijing Tiantan Biological Products Corporation news

We have not published a story on Beijing Tiantan Biological Products Corporation yet. When there is news, it will appear here.

Questions about Beijing Tiantan Biological Products Corporation

What is the ticker symbol of Beijing Tiantan Biological Products Corporation?

Beijing Tiantan Biological Products Corporation Limited trades under the ticker 600161 on SSE.

Where is Beijing Tiantan Biological Products Corporation listed?

Beijing Tiantan Biological Products Corporation Limited is listed on SSE.

Which country or territory is Beijing Tiantan Biological Products Corporation listed under?

Our directory records Beijing Tiantan Biological Products Corporation Limited under China.

What does Beijing Tiantan Biological Products Corporation do?

Our directory classifies Beijing Tiantan Biological Products Corporation Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Beijing Tiantan Biological Products Corporation?

The ISIN recorded for Beijing Tiantan Biological Products Corporation Limited is CNE000000WF9.

Does aibio.space cover Beijing Tiantan Biological Products Corporation?

aibio.space lists Beijing Tiantan Biological Products Corporation Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Beijing Tiantan Biological Products Corporation?

Companies in our directory listed in the same country and business area as Beijing Tiantan Biological Products Corporation: Pacific Shuanglin Bio-pharmacy Co., Hubei Goto Biopharm Group Co., Shanghai Obio Technology (Group) Corp., Boji Medical Technology Co., Hualan Biological Engineering, Hanx Biopharmaceuticals (Wuhan) Co..

Investor discussion: Beijing Tiantan Biological Products Corporation

Members talk about Beijing Tiantan Biological Products Corporation (600161). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600161 on TradingView.

Listing details

Beijing Tiantan Biological Products Corporation Limited is a public biotech or pharmaceutical company listed on SSE under the ticker 600161, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Beijing Tiantan Biological Products Corporation Limited
Ticker
600161
Listing
SSE
Country or territory
China
Business scope
Biotechnology
ISIN
CNE000000WF9
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.